It also inhibits the aggregation of amyloid‐beta (Aβ) peptides and hyperphosphorylated tau protein—hallmarks of AD—by modulating kinases like GSK‐3β, thus preventing plaque and tangle formation (Rahul and Siddique 2021). Here, MAPT is linked to Alzheimer disease.